Skip to main content
48°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Revelation Biosciences Inc
(NQ:
REVB
)
0.7523
-0.0007 (-0.09%)
Streaming Delayed Price
Updated: 9:35 AM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Revelation Biosciences Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference
March 06, 2023
From
Revelation Biosciences Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
February 14, 2023
During Tuesday, 40 stocks hit new 52-week lows.
Via
Benzinga
Revelation Biosciences Inc. Announces Closing of $15.6 Million Public Offering
February 13, 2023
From
Revelation Biosciences Inc.
Via
Business Wire
Revelation Biosciences Outlines Plans Human Trial For Lead Fibrosis Candidate
November 18, 2022
Via
Benzinga
Why Revelation Biosciences Is Trading 40% Lower Thursday
February 09, 2023
Revelation Biosciences Inc (NASDAQ: REVB) shares are trading lower by 41.98% Thursday afternoon. The company priced a 3.225 million share offering for gross proceeds of $15.6 million. What Else?
Via
Benzinga
Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 09, 2023
Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday.
Via
Benzinga
US Stocks Turn Lower; Dow Drops 50 Points
February 09, 2023
U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 50 points on Thursday. The Dow traded down 0.15% to 33,897.48 while the NASDAQ fell 0.12% to 11,896.28. The S&P 500...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 09, 2023
Via
Benzinga
Wall Street Cautiously Optimistic At Midday
February 09, 2023
The Dow Jones Industrial Average is up 108 points midday. The S&P 500 and Nasdaq Composite are both higher as well.
Via
Talk Markets
Dow Jumps 250 Points; US Jobless Claims Increase Last Week
February 09, 2023
U.S. stocks traded higher this morning, with the Dow Jones jumping around 250 points on Thursday. The Dow traded up 0.75% to 34,204.99 while the NASDAQ rose 1.15% to 12,047.28. The S&P 500 also rose,...
Via
Benzinga
Revelation Biosciences Inc. Announces Pricing of $15.6 Million Public Offering
February 09, 2023
From
Revelation Biosciences Inc.
Via
Business Wire
Why Cardiovascular Systems Shares Are Trading Higher By 48%; Here Are 20 Stocks Moving Premarket
February 09, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 09, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
February 09, 2023
We're starting off another day of trading with a look at the biggest pre-market stock movers investors need to watch for Wednesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 08, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
February 08, 2023
On Wednesday, 20 companies achieved new lows for the year.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 07, 2023
Via
Benzinga
Revelation Biosciences Reveals Encouraging Preclinical Data From Its Lead Fibrosis Candidate
February 07, 2023
Via
Benzinga
Revelation Biosciences Inc. Announces Preclinical Biomarker Data Supporting Activity of REVTx-300
February 07, 2023
From
Revelation Biosciences Inc.
Via
Business Wire
Revelation Biosciences Inc. Announces 1-for-35 Reverse Stock Split effective February 1, 2023 and Results of Special Meeting of Stockholders
January 31, 2023
From
Revelation Biosciences Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 24, 2023
Via
Benzinga
Why LogicMark Shares Are Trading Lower By Around 25%; Here Are 20 Stocks Moving Premarket
January 24, 2023
Gainers Axcella Health Inc. (NASDAQ: AXLA) rose 71.7% to $0.7450 in pre-market trading after the company reported regulatory path to registration of AXA1125 for long COVID-19 fatigue.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 17, 2023
Via
Benzinga
Revelation Biosciences Inc. Announces Mandatory Unit Separation to Occur on January 13, 2023
January 10, 2023
From
Revelation Biosciences Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 10, 2023
We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about for Tuesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
January 06, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 13, 2022
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Tuesday morning!
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
December 02, 2022
We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about for Friday morning!
Via
InvestorPlace
Earnings Scheduled For November 21, 2022
November 21, 2022
Companies Reporting Before The Bell • Zepp Health (NYSE:ZEPP) is expected to report quarterly earnings at $0.54 per share on revenue of $186.58 million.
Via
Benzinga
Revelation Biosciences Inc. Announces Future Clinical Development Plans Based on Recent Biomarker Analysis and Significant Reduction in New Collagen Deposition (Fibrosis) in Preclinical Model
November 18, 2022
From
Revelation Biosciences Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.